Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
about
A comparison of efficacy and toxicity between electroporation and adenoviral gene transferPostnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse modelVirus-mediated gene transfer to induce therapeutic angiogenesis: where do we stand?In vivo acceleration of heart relaxation performance by parvalbumin gene deliveryBaculovirus vectors repress phenobarbital-mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes.Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice.Tolerance induction to cytoplasmic beta-galactosidase by hepatic AAV gene transfer: implications for antigen presentation and immunotoxicityLongitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.Identification of sites in adenovirus hexon for foreign peptide incorporation.Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers.Circumvention of immunity to the adenovirus major coat protein hexon.Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles.Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administrationCD40 ligand-dependent activation of cytotoxic T lymphocytes by adeno-associated virus vectors in vivo: role of immature dendritic cells.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsAdenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.Migration of dendritic cells from murine skeletal muscle.Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity.Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectorsAdeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heartAAV-mediated in vivo functional selection of tissue-protective factors against ischaemiaEffect of rapamycin on immunity induced by vector-mediated dystrophin expression in mdx skeletal muscleStable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus.Long-term survival of transplanted stem cells in immunocompetent mice with muscular dystrophy.High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.The companions: regulatory T cells and gene therapy.In vivo delivery of a microRNA-regulated transgene induces antigen-specific regulatory T cells and promotes immunologic tolerance.Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus.Selection-free gene repair after adenoviral vector transduction of designer nucleases: rescue of dystrophin synthesis in DMD muscle cell populations.Progress toward Gene Therapy for Duchenne Muscular Dystrophy.Frequency and stability of chromosomal integration of adenovirus vectors.Muscle-specific overexpression of the adenovirus primary receptor CAR overcomes low efficiency of gene transfer to mature skeletal muscle.Biology of E1-deleted adenovirus vectors in nonhuman primate muscle.Robust hypoxia-selective regulation of a retinal pigment epithelium-specific adeno-associated virus vectorCreation of immune 'stealth' genes for gene therapy through fusion with the Gly-Ala repeat of EBNA-1.Overcoming cellular immunity to prolong adenoviral-mediated gene expression in sciatic nerve.The fate of individual myoblasts after transplantation into muscles of DMD patients.
P2860
Q24799546-122E2259-9372-4535-83C4-D69B5E0D52B5Q27324722-0A079866-4338-481A-8786-B8E005F1B788Q30489689-D9C6EBC2-13D4-4934-BE9B-9850F684EE0FQ30501538-4823D29F-1D64-4C41-AFD5-0CFADE7DE6EDQ31418343-62D275CB-E95F-41F5-9F1E-15FA159DE2E3Q33364523-374B27BB-8DFD-4DCE-B21F-E6A9492FD53AQ33490137-3916380C-C44C-442D-BF18-64994CFC63BFQ33630150-7F10FA43-7D95-456E-9189-426FA811AD6DQ33737591-0583A475-DF2B-406C-9AE5-66E2C4891040Q33782516-4B30831B-1F2C-4E22-BAC5-1FE09674DCF9Q33782809-F2E2909C-4CA5-4AE0-83A7-12D52818AAE4Q33783658-748D6360-5412-4434-93D4-8CA5A09A4874Q33783905-E7FD76F1-CF51-4C89-9F31-B66D9C6687E3Q33783991-3B2BBAA6-64FB-40B9-ABEB-624D7762CB92Q33810726-BAB7B8CB-1286-4CAA-9A0A-3505354E6BC9Q33817535-6F907C60-62DD-453C-85C2-3CCFC15EB8BBQ33818043-286B48F3-F32E-453C-8EE4-AB5DA5CFB7B7Q33848838-866ACAF4-9994-4D91-9785-631D712260C3Q34283316-59E4DA70-DA48-496C-9D2C-424B1BEFB9F6Q34352485-5D091981-F2BC-40DA-B6CC-1BCF2A6BDADDQ34365087-7F7670B8-AA15-40C1-B5D9-E75769B0269CQ35085243-EA9D11A3-3E9B-43E1-842C-13292A6CCB1CQ35576360-44682C14-A22B-48FE-971D-B53049446D32Q35661326-D6F994E9-7CF1-4808-A262-2CC37D3FD847Q35943638-EEDD1812-37F6-4978-A860-943A9890A8B7Q36159178-2AD2E60B-770B-48D8-8D70-EB721400B333Q36855708-129CC21E-84E2-4893-A05A-345D6FDA0009Q37381930-F11E5A1F-94F6-4F85-A489-27BE0EEEC186Q37445093-6A4E74DF-59BE-484D-A347-2197CBC22102Q37472002-1094EA98-97FF-4029-AE0A-62668DAA1E6CQ37684597-857C1DB7-E692-4655-B072-F6CE941B5DA1Q38531000-13DD9877-DD76-4CD1-883D-F99FB742BE3DQ39246797-28F18A96-AAF8-4B91-81B2-55D33877AEBAQ39594975-9E8CFE22-E0E1-4265-A30A-2B075E3D6710Q39602470-BB98FE88-8705-462A-9F7C-4943C41B1971Q39606172-B8C42746-A8C0-40CC-B653-768A5D7AF90BQ40003426-DBFC61C6-9B47-44F7-89BB-E8FFB0D0CEE0Q40625018-7656C9F2-21B5-4AAC-B6E4-4E1EF39A0AB0Q40787419-11B51786-94FC-4CD8-92FD-FF7B4B948272Q40883106-5D5C830C-12DB-47B2-B01D-29198DCAD58C
P2860
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@en
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@nl
type
label
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@en
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@nl
prefLabel
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@en
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle.
@nl
P2093
P356
P1476
Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle
@en
P2093
P304
P356
10.1093/HMG/5.11.1703
P577
1996-11-01T00:00:00Z